Key point Considering that vaccination with the sIPV and DTaP overlap at the ages of 3 and
4 months in China, to reduce the burden of treatment on parents and increase vaccination …

Objectives During the COVID-19 pandemic, there was a decline in vaccine coverage, and
the implementation of combined vaccines and co-administration strategies emerged as …

ABSTRACT Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and
inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including …

Background: With the goal of global eradication of poliomyelitis due to wild-type viruses
within sight, WHO now recommends that infants receive at least one dose of trivalent …

Background: Combined vaccines are urgently needed to ensure compliance with the
increasing number of recommended vaccines for children. We evaluated the safety and …

Abstract Introduction TETRAXIM™(Sanofi), a combined diphtheria, tetanus, acellular
pertussis, and inactivated poliovirus (DTaP-IPV) vaccine, has been licensed in South Korea …

This randomized trial enrolled 442 infants in the Republic of Korea to assess the
immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and …

The aim was to demonstrate the immunogenicity and safety of a DTaP-IPV//PRP-T combined
vaccine (Pentaxim®) compared to individual vaccines in infants in the People's Republic of …

Background: Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …

abstract The introduction of combination vaccines plays a significant role in increasing
vaccine acceptance and widening vaccine coverage. Primary vaccination against …